P3 Health Partners
PIII
13 hedge funds and large institutions have $954K invested in P3 Health Partners in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 2 closing their positions.
1.74% less ownership
Funds ownership: 10.05% → 8.31% (-1.7%)
13% less funds holding
Funds holding: 15 → 13 (-2)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
93% less capital inflows, than outflows
Capital inflows: $30.1K | Capital outflows: $404K
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Trinity Financial Advisors
Columbus,
Ohio
|
+$13.4K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$6.97K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5.52K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$3.38K |
| 5 |
BlackRock
New York
|
+$818 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$294K |
| 2 |
Corient Private Wealth
Miami,
Florida
|
-$98.3K |
| 3 |
JP Morgan Chase
New York
|
-$6.76K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.05K |
| 5 |
Barclays
London,
United Kingdom
|
-$590 |
PIII Hedge Fund Activity: Q4 2025 in Review
13 of the 8,307 institutional investors tracked by Wall St. Rank reported a position in P3 Health Partners (PIII) for Q4 2025, worth a combined $954K — down 68% from $2.95M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PIII and 0 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 5 added.
The largest buyer was Trinity Financial Advisors, adding an estimated $13.4K. The largest seller was Alyeska Investment Group, cutting an estimated $294K.
- 13 institutional investors held P3 Health Partners (PIII) as of Q4 2025, down from 15 in Q3 2025.
- Funds reported $954K of P3 Health Partners stock for Q4 2025, down 68% quarter-over-quarter.
- 0 funds opened new P3 Health Partners positions in Q4 2025 and 2 closed out, a net change of -2 holders.
- The largest P3 Health Partners buyer in Q4 2025 was Trinity Financial Advisors, an estimated $13.4K added.
- The largest P3 Health Partners seller in Q4 2025 was Alyeska Investment Group, an estimated $294K sold.
Based on aggregated 13F filings for Q4 2025.